Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: A randomized controlled trial

Journal of Hospital Infection

Volumn 37, Issue 2, 1997, Pages 145-156

  Logghe, C ^a   Van Ossel, Ch ^a   D'Hoore, W ^a   Ezzedine, H ^a   Wauters, G ^a   Haxhe, J J ^a,b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Ecole de Sante Publique   (Belgium)

Author keywords

Bacteraemia; Central venous catheter; Chlorhexidine; Haematology; Oncology; Silver sulfadiazine; Vascular catheter

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CHLORHEXIDINE; SULFADIAZINE SILVER;

ADULT; AGED; ARTICLE; BACTEREMIA; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INFECTION RATE; INFECTION RISK; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030819751     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(97)90184-5     Document Type: Article

References (46)

1. Pearson ML. Guideline for prevention of intravascular-device related infections. Inf Control Hosp Epidemiol 1996; 17: 438-473.
2. Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 1981; 70: 739-744.
3. Zakrzewskabode A, Muytjens HL, Liem KD, Hoogkampkorstanje JAA. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect 1995; 31: 189-193.
4. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339-343.
5. Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 1994; 22: 1729-1737.
6. Engervall P, Ringertz S, Hagman E, Skogman K, Bjorkholm M. Change of central venous catheter dressings twice a week is superior to once a week in patients with haematological malignancies. J Hosp Infect 1995; 29: 275-286.
7. Sheth NK, Franson TR, Rose HD, Buckmire FL, Cooper JA, Sohnle PG. Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol 1983; 18: 1061-1063.
8. Sheth NK, Rose HD, Franson TR, Buckmire FL, Sohnle PG. In vitro quantitative adherence of bacteria to intravascular catheters. J Surg Res 1983; 34: 213-218.
9. Meister D, Furst A, Kaetgi B, Struchen C, Kaser-Hotz B, Fluckiger M. Experiences with long-term intravenous therapy using teflon catheters in 80 horses. Tierarztl Prax 1993; 21: 437-443.
10. Raad I, Davis S, Becker M, et al. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med 1993; 153: 1791-1796.
11. Tebbs SE, Sawyer A, Elliott TS. Influence of surface morphology on in vitro bacterial adherence to central venous catheters. Br J Anaesth 1994; 72: 587-591.
12. Sherertz RJ, Carruth WA, Marosok RD, Espeland MA, Johnson RA, Solomon DD. Contribution of vascular catheter material to the pathogenesis of infection: the enhanced risk of silicone in vivo. J Biomed Mater Res 1995; 29: 635-645.
13. Maki DG, Cobb L, Garman JK, Shapiro JM, Ringer M, Helgerson RB. An attachable silver-impregnated cuff for prevention of infection with central venous catheters: a prospective randomized multicenter trial. Am J Med 1988; 85: 307-314.
14. Flowers RH, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA 1989; 261: 878-883.
15. Hasaniya NW, Angelis M, Brown MR, Yu M. Efficacy of subcutaneous silver-impregnated cuffs in preventing central venous catheter infections. Chest 1996; 109: 1030-1032.
16. Trooskin SZ, Donetz AP, Harvey RA, Greco RS. Prevention of catheter sepsis by antibiotic bonding. Surgery 1985; 97: 547-551.
17. Kamal GD, Pfaller MA, Rempe LE, Jebson PJ. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 1991; 265: 2364-2368.
18. Romano G, Berti M, Goldstein BP, Borghi A. Efficacy of a central venous catheter (Hydrocath) loaded with teicoplanin in preventing subcutaneous staphylococcal infection in the mouse. Int J Med Microbiol Virol Parasitol Infect Dis 1993; 279: 426-433.
19. Sherertz RJ, Carruth WA, Hampton AA, Byron MP, Solomon DD. Efficacy of antibiotic-coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis 1993; 167: 98-106.
20. Raad I, Darouiche R, Hachem R, Sacilowski M, Bodey GP. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 1995; 39: 2397-2400.
21. Raad I, Darouiche R, Hachem R, Mansouri M, Bodey GP. The broad-spectrum activity and efficacy of catheters coated with minocyline and rifampin. J Infect Dis 1996; 173: 418-424.
22. Jansen B, Rinck M, Wolbring P, Strohmeier A, Jahns T. In vitro evaluation of the antimicrobial efficacy and biocompatibility of a silver-coated central venous catheter. J Biomater Appl 1994; 9: 55-70.
23. Raad I, Hachem R, Zermeno A, Stephens LC, Bodey GP. Silver iontophoretic catheter; A prototype of a long-term antiinfective vascular access device. J Infect Dis 1996; 173: 495-498.
24. Carruth WA, Byron MP, Solomon DD, et al. Subcutaneous, catheter-related inflammation in a rabbit model correlates with peripheral vein phlebitis in human volunteers. J Biomed Mater Res 1994; 28: 259-267.
25. Tebbs SE, Elliott TS. A novel antimicrobial central venous catheter impregnated with benzalkonium chloride. J Antimicrob Chemother 1993; 31: 261-271.
26. Tebbs SE, Elliott TS. Modification of central venous catheter polymers to prevent in vitro microbial colonisation. Eur J Clin Microbiol Infect Dis 1994; 13: 111-117.
27. Sampath LA, Chowdhury N, Caraos L, Modak SM. Infection resistance of surface modified catheters with either short-lived or prolonged activity, J Hosp Infect 1995; 30: 201-210.
28. Maki DG, Wheeler SJ, Stolz SM. Study of a novel antiseptic-coated central venous catheter. Crit Care Med 1991; 19 (Suppl.): 99S. Abstract.
29. Modak SH, Sampath L. Development and evaluation of a new polyurethane central venous antiseptic catheter: reducing central venous catheter infections. Complications in Surgery 1992; June: 23-29.
30. Bach A, Bohrer H, Motsch J, Martin E, Geiss HK, Sonntag HG. Prevention of catheter-related infections by antiseptic bonding. J Surg Res 1993; 55: 640-646.
31. Bach A, Bohrer H, Motsch J, Martin E, Geiss HK, Sonntag HG. Prevention of bacterial colonization of intravenous catheters by antiseptic impregnation of polyurethane polymers. J Antimicrob Chemother 1994; 33: 969-978.
32. Mermel LA, Stolz SM, Maki DG. Surface antimicrobial activity of heparin-bonded and antiseptic-impregnated vascular catheters. J Infect Dis 1993; 167: 920-924.
33. van Heerden PV, Webb SAR, Fong S, Golledges CL, Roberts BL, Thompson WR. Central venous catheters revisited - Infection rates and an assessment of the new fibrin analysing system brush. Anaesth Intens Care 1996; 24: 330-333.
34. Yagupsky P, Nolte FS. Quantitative aspects of septicemia. Clin Microb Rev 1990; 3: 269-279.
35. Fan ST, Teoh Chan CH, Lau KF. Evaluation of central venous catheter sepsis by differential quantitative blood culture. Eur J Clin Microbiol Infect Dis 1989; 8: 142-144.
36. Fleiss JL, Statistical methods for Rates and Proportions, 2nd Edn, New York: J. Wiley & Sons 1981.
37. Greenfeld JI, Sampath L, Popilskis SJ, Brunnert SR, Stylianos S, Modak S. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine. Crit Care Med 1995; 23: 894-900.
38. Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 1996; 62: 61-646.
39. Pemberton LB, Ross V, Cuddy P, Kremer H, Fessler T, McGurk E. No difference in catheter sepsis between standard and antiseptic central venous catheters. Arch Surg 1996; 131: 986-989.
40. Groeger JS, Lucas AB, Coit D, et al. A prospective, randomized evaluation of the effect of silver impregnated subcutaneous cuffs for preventing tunneled chronic venous access infections in cancer patients. Ann Surg 1993; 218: 206-210.
41. Sitges-Serra A, Puig P, Linares J, et al. Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. J Parent Enterai Nutr 1984; 8: 668-672.
42. Linares J, Sitges-Serra A, Garau J, Perez JL, Martin R. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Parent Enterai Nutr 1985; 21: 357-360.
43. Sitges-Serra A, Pi-Sunner T, Garces JM, Segura M. Pathogenesis and prevention of catheter-related septicemia. Am J Infect Control 1995; 23: 310-316.
44. Segura M, Alvarez-Lerma F, Tellado JM, et al. A clinical trial on the prevention of catheter-related sepsis using a new hub model. Ann Surg 1996; 223: 363-369.
45. Raad I. Vascular catheters impregnated with antimicrobial agents: present knowledge and future direction. Inf Control Hosp Epidemiol 1997; 18: 227-229.
46. Anaissie E, Samonis G, Kontoyiannis D, et al. Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis 1995; 14: 134-137.